900000000000508004: Great Britain English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\GB English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
GB English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
1A3 (UICC)	Acceptable (foundation metadata concept)
1B	Preferred (foundation metadata concept)
1B (AJCC)	Acceptable (foundation metadata concept)
1B (UICC)	Acceptable (foundation metadata concept)
1B (qualifier value)	Preferred (foundation metadata concept)
1B1 (AJCC)	Acceptable (foundation metadata concept)
1B1 (UICC)	Acceptable (foundation metadata concept)
1B2 (AJCC)	Acceptable (foundation metadata concept)
1B2 (UICC)	Acceptable (foundation metadata concept)
1B3 (AJCC)	Acceptable (foundation metadata concept)
1B3 (UICC)	Acceptable (foundation metadata concept)
1C (AJCC)	Acceptable (foundation metadata concept)
1C (UICC)	Acceptable (foundation metadata concept)
1D cold incubation	Acceptable (foundation metadata concept)
1D post incubation	Acceptable (foundation metadata concept)
1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol aminotransferase	Preferred (foundation metadata concept)
1D-1-guanidino-3-amino-1,3-dideoxy-scyllo-inositol aminotransferase (substance)	Preferred (foundation metadata concept)
1D-myo-inositol-tetrakisphosphate 1-kinase	Preferred (foundation metadata concept)
1D-myo-inositol-tetrakisphosphate 1-kinase (substance)	Preferred (foundation metadata concept)
1D-myo-inositol-tetrakisphosphate 5-kinase	Preferred (foundation metadata concept)
1D-myo-inositol-tetrakisphosphate 5-kinase (substance)	Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 3-kinase	Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 3-kinase (substance)	Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 5-kinase	Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 5-kinase (substance)	Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 6-kinase	Preferred (foundation metadata concept)
1D-myo-inositol-trisphosphate 6-kinase (substance)	Preferred (foundation metadata concept)
1E (AJCC)	Acceptable (foundation metadata concept)
1E (UICC)	Acceptable (foundation metadata concept)
1H post 100 g glucose PO	Acceptable (foundation metadata concept)
1H post 50 g glucose PO	Acceptable (foundation metadata concept)
1H post 75 g glucose PO	Acceptable (foundation metadata concept)
1H post dose corticotropin	Acceptable (foundation metadata concept)
1H post dose glucose	Acceptable (foundation metadata concept)
1H post incubation	Acceptable (foundation metadata concept)
1H post meal	Acceptable (foundation metadata concept)
1H post resting	Acceptable (foundation metadata concept)
1H-3-hydroxy-4-oxoquinoline 2,4-dioxygenase	Acceptable (foundation metadata concept)
1H-Benzotriazol	Preferred (foundation metadata concept)
1H-Benzotriazol	Preferred (foundation metadata concept)
1H-Benzotriazol (product)	Preferred (foundation metadata concept)
1H-Benzotriazol (substance)	Preferred (foundation metadata concept)
1H-Benzotriazole	Acceptable (foundation metadata concept)
1H-Pyrazole-3-ethanamine	Acceptable (foundation metadata concept)
1H-Pyrazole-3-ethanamine dihydrochloride	Acceptable (foundation metadata concept)
1L-myo-Inositol-1-phosphatase	Preferred (foundation metadata concept)
1L-myo-Inositol-1-phosphatase (substance)	Preferred (foundation metadata concept)
1S (AJCC)	Acceptable (foundation metadata concept)
1S (UICC)	Acceptable (foundation metadata concept)
1p partial monosomy	Preferred (foundation metadata concept)
1p partial monosomy (disorder)	Preferred (foundation metadata concept)
1p21.3 microdeletion syndrome	Preferred (foundation metadata concept)
1p21.3 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
1p21.3 microdeletion syndrome is an extremely rare chromosomal anomaly characterised by severe speech and language delay, intellectual deficiency, autism spectrum disorder.	Preferred (foundation metadata concept)
1p31p32 microdeletion syndrome	Preferred (foundation metadata concept)
1p31p32 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
1p31p32 microdeletion syndrome is a rare chromosomal anomaly syndrome, resulting from the partial deletion of the short arm of chromosome 1, characterised by developmental delay, corpus callosum agenesis/hypoplasia and craniofacial dysmorphism, such as macrocephaly (caused by hydrocephalus or ventriculomegaly), low-set ears, anteverted nostrils and micrognathia. Urinary tract defects (e.g. vesicoureteral reflux, urinary incontinence) are also frequently associated. Other reported variable manifestations include hypotonia, tethered spinal cord, Chiari type I malformation and seizures.	Preferred (foundation metadata concept)
1p35.2 microdeletion syndrome	Preferred (foundation metadata concept)
1p35.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
1p36 deletion syndrome	Preferred (foundation metadata concept)
1q partial monosomy	Preferred (foundation metadata concept)
1q partial monosomy (disorder)	Preferred (foundation metadata concept)
1q partial trisomy syndrome	Preferred (foundation metadata concept)
1q partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
1q21.1 contiguous gene deletion	Acceptable (foundation metadata concept)
1q21.1 microdeletion	Preferred (foundation metadata concept)
1q21.1 microdeletion syndrome	Acceptable (foundation metadata concept)
1q21.1 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
1q21.1 microduplication syndrome	Preferred (foundation metadata concept)
1q21.1 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
1q21.1 microduplication syndrome is a rare partial autosomal trisomy/tetrasomy with incomplete penetrance and variable expression characterised by macrocephaly, developmental delay, intellectual disability, psychiatric disturbances (autism spectrum disorder, attention deficit hyperactivity disorder, schizophrenia, mood disorders) and mild facial dysmorphism (high forehead, hypertelorism). Other associated features include congenital heart defects, hypotonia, short stature, scoliosis.	Preferred (foundation metadata concept)
1q41-q42 microdeletion syndrome	Acceptable (foundation metadata concept)
1q41q42 microdeletion syndrome	Preferred (foundation metadata concept)
1q41q42 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
1q41q42 microdeletion syndrome is a chromosomal anomaly characterised by a severe developmental delay and/or intellectual disability, typical facial dysmorphic features, brain anomalies, seizures, cleft palate, clubfeet, nail hypoplasia and congenital heart disease.	Preferred (foundation metadata concept)
1q44 microdeletion syndrome	Preferred (foundation metadata concept)
1q44 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
1q44 microdeletion syndrome is a newly described syndrome associated with facial dysmorphism, developmental delay, in particular of expressive speech, seizures and hypotonia.	Preferred (foundation metadata concept)
1st	Acceptable (foundation metadata concept)
1st HiB and DTP vaccine given	Preferred (foundation metadata concept)
1st HiB and DTP vaccine given (situation)	Preferred (foundation metadata concept)
1st Hib and DTP vaccine given	Preferred (foundation metadata concept)
1st Japanese encephalitis vaccination	Preferred (foundation metadata concept)
1st Japanese encephalitis vaccination	Preferred (foundation metadata concept)
1st Japanese encephalitis vaccination (procedure)	Preferred (foundation metadata concept)
1st Japanese encephalitis vaccination (procedure)	Preferred (foundation metadata concept)
1st floor	Acceptable (foundation metadata concept)
1st heart sound split	Acceptable (foundation metadata concept)
1st hepatitis A junior vaccination	Acceptable (foundation metadata concept)
1st left lumbar vein	Acceptable (foundation metadata concept)
1st right lumbar vein	Acceptable (foundation metadata concept)
1st specimen	Acceptable (foundation metadata concept)
1st trimester	Acceptable (foundation metadata concept)
2	Preferred (foundation metadata concept)
2	Preferred (foundation metadata concept)
2 (AJCC)	Acceptable (foundation metadata concept)
2 (UICC)	Acceptable (foundation metadata concept)
2 (qualifier value)	Preferred (foundation metadata concept)
2 ASD - Secundum atrial septal defect	Acceptable (foundation metadata concept)
2 bulky (AJCC)	Acceptable (foundation metadata concept)
2 bulky (UICC)	Acceptable (foundation metadata concept)

Start Previous Page 79 of 13273 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001112010	Great Britain English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001113017	GB English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001114011	Great Britain English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)